0000898432-19-001517.txt : 20191220 0000898432-19-001517.hdr.sgml : 20191220 20191220203444 ACCESSION NUMBER: 0000898432-19-001517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191219 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON BRENT CENTRAL INDEX KEY: 0001254747 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36534 FILM NUMBER: 191303268 MAIL ADDRESS: STREET 1: 4900 HOPYARD RD STREET 2: SUITE 210 CITY: PLEASITAN STATE: CA ZIP: 94588 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRADIMED CORP CENTRAL INDEX KEY: 0001325618 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 731408526 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 BUSINESS PHONE: 4076778022 MAIL ADDRESS: STREET 1: 1025 WILLA SPRINGS DR. CITY: WINTER SPRINGS STATE: FL ZIP: 32708 4 1 form4.xml X0306 4 2019-12-19 0001325618 IRADIMED CORP IRMD 0001254747 JOHNSON BRENT C/O IRADIMED CORPORATION 1025 WILLA SPRINGS DR. WINTER SPRINGS FL 32708 true Exec. VP of WW Sales and Mktg Common Stock 2019-12-19 4 A 0 8000 0.93 A 10566 D Common Stock 2019-12-19 4 S 0 8000 25.65 D 2566 D Common Stock 2019-12-20 4 A 0 8000 0.93 A 10566 D Common Stock 2019-12-20 4 S 0 8000 25.33 D 2566 D Stock Option (Right to Buy) 0.93 2019-12-19 4 M 0 8000 0 D 2022-11-01 Common Stock 8000 180468 D Stock Option (Right to Buy) 0.93 2019-12-20 4 M 0 8000 0 D 2022-11-01 Common Stock 8000 172468 D The exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. This transaction was executed in multiple trades at prices ranging from $25.47 to $25.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This option, representing a right to purchase a total of 278,408 shares, was granted on November 1, 2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date. /s/ Brent Johnson 2019-12-20